Toronto, Ontario–(Newsfile Corp. – November 30, 2021) – Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’ or the ‘Company’), a biotechnology company developing and delivering psychedelic therapeutics (medicines and therapies) to treat addiction, announced today the execution of an agreement to appoint Kate Butler as new Chief Financial Officer (“CFO”), and Jonathan Held…


Previous articlePT275 – James Fadiman, Ph.D. – Transpersonal Psychology, Microdosing, and Your Symphony of Selves
Next articleIbogaine and Cardiac Arrhythmia: The Heart of the Matter